Molecular target
D1 Dopamine Receptor
Excitatory dopamine receptor in motor, cognitive, and reward circuits. Targeted indirectly by levodopa-precursor strategies.
Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.
No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.
Pharmaceutical agents
Drugs that act on D1 Dopamine Receptor
These medications have D1 Dopamine Receptor among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.
Botanical connections
Plants whose compounds act on D1 Dopamine Receptor
Each plant below contains a named compound documented to act on D1 Dopamine Receptor. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.
- L-DOPACatecholamine precursor (amino acid)
Direct levodopa — chemically identical to the prescription drug. After hepatic + CNS decarboxylation, L-DOPA becomes dopamine, raising D1/D2 activity. The reason Mucuna is functionally a Parkinson’s drug, not a supplement.
- Aporphine alkaloids (apomorphine traces)Aporphine alkaloid
Trace dopaminergic alkaloids contributing to subjective effects.